EIG's mission is to develop highly accurate and non-invasive multi-omic molecular testing solutions for complex diseases like cancer. The company has developed a Multi-omic Integration Platform that combines detection of DNA, RNA, protein and metabolite targets into a single assay. This breakthrough approach transforms the field of molecular diagnostics by offering unparalleled accuracy with comprehensive insights for early disease detection. www.earlyisgood.com.
External link for Early is Good
1210 Waterway Blvd
Indianapolis, Indiana 46202, US
Early is Good reposted this
Bladder cancer is highly recurrent. Patients need better monitoring tools. With a $1.6M NIH grant, Early is Good is advancing BCDx—a multi-omic urine test to detect recurrence early, non-invasively. Thank you, NIH, for supporting this important need. #BladderCancer #NIH #EarlyIsGood #BCDx https://lnkd.in/gJmkFgnn
Early is Good reposted this
We’re looking for a Senior Scientist to join our Assay Product Development team and drive the development, optimization, and validation of our nanotechnology-based multi-omics assays. Feel free to reach out if you have any questions. https://lnkd.in/gQK4bYu4
Early is Good reposted this
Early is Good is pleased to announce our #collaboration with Mayo Clinic to develop a liquid biopsy test for advanced prostate cancer. This collaboration aims to develop a comprehensive care plans for the approx 50,000 men diagnosed annually in the US with metastatic castration-resistant prostate cancer (#mCRPC). This collaboration highlights the potential of our #Multiomic Integration Platform to advance cancer care through improved detection and treatment selections. https://lnkd.in/gnnRHdd7
Early is Good reposted this
Saturday morning at the #NCCN2024 Annual Conference included a plenary session on the Impact of Drug Shortages on Cancer Care, information on Appropriate Vaccinations for Patients in Survivorship, poster tours, and more. Tune in: NCCN.org/Conference
Early is Good reposted this
Excited to present the validation data of our bladder cancer diagnostic test at the #NCCN Annual Conference tomorrow (April 6th) with my co-founder, Asel Liyanage. Catch us at Poster #109, 7:30 AM - 3:35 PM. Looking forward to interesting discussions! https://lnkd.in/dezuhr6g #nccn #bladdercancer #bcdx
We are excited to welcome Dr. Eric Kim as our Vice President of Clinical Sciences. Dr. Kim is a uro-oncologist at Washington University, specializing in bladder, kidney, and prostate cancers with extensive research work in imaging and biomarkers. His understanding of the unmet needs in the patient’s cancer journey from diagnosis through treatment selection, along with his expertise in clinical trials will greatly advance EIG's mission of creating diagnostics for early accurate detection and improved treatment of cancer. #earlyisgood #urology #oncology #bladdercancer #prostatecancer
#LifeScienceSummit2023 has put a spotlight on the importance of #earlydetection. Impressive to see #Indiana at the forefront of this vital movement, leading the way in preventive healthcare.